ApoA-V(ab) Monoclonal Antibody

    • 货号:YM0034
    • 应用:WB;ELISA
    • 种属:Human
      • 靶点:
      • ApoA-V
      • 简介:
      • >>PPAR signaling pathway
      • 基因名称:
      • APOA5
      • 蛋白名称:
      • Apolipoprotein A-V
      • Human Swiss Prot No:
      • Q6Q788
      • Mouse Swiss Prot No:
      • Q8C7G5
      • 免疫原:
      • Purified recombinant fragment of human ApoA-V expressed in E. Coli.
      • 特异性:
      • ApoA-V(ab) Monoclonal Antibody detects endogenous levels of ApoA-V(ab) protein.
      • 组成:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • 来源:
      • Monoclonal, Mouse
      • 稀释:
      • WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.
      • 纯化工艺:
      • Affinity purification
      • 浓度:
      • 1 mg/ml
      • 储存:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • 其他名称:
      • APOA5;RAP3;Apolipoprotein A-V;Apo-AV;ApoA-V;Apolipoprotein A5;Regeneration-associated protein 3
      • 分子量:
      • 41kD
      • 背景:
      • The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009],
      • 功能:
      • caution:It is uncertain whether Met-1 or Met-4 is the initiator.,disease:Defects in APOA5 are a cause of hyperlipoproteinemia type 5 [MIM:144650]. Hyperlipoproteinemia type 5 is characterized by increased amounts of chylomicrons and very low density lipoprotein (VLDL) and decreased low density lipoprotein (LDL) and high density lipoprotein (HDL) in the plasma after a fast. Numerous conditions cause this phenotype, including insulin-dependent diabetes mellitus, contraceptive steroids, alcohol abuse, and glycogen storage disease type 1A (GSD1A) [MIM:232200].,disease:Defects in APOA5 are a cause of susceptibility to familial hypertriglyceridemia [MIM:145750]. It is a coronary heart disease risk factor. On a regular diet the patient demonstrates increased plasma VLDL. Plasma triglycerides are persistently increased, while plasma cholesterol and phospholipids are usually within normal limits.
      • 细胞定位:
      • Secreted . Early endosome . Late endosome . Golgi apparatus, trans-Golgi network . In the presence of SORL1, internalized to early endosomes, sorted in a retrograde fashion to late endosomes, from which a portion is sent to lysosomes and degradation, another portion is sorted to the trans-Golgi network. .
      • 组织表达:
      • Liver and plasma.
      • 产品图片
      • Western Blot analysis using ApoA-V(ab) Monoclonal Antibody against human serum (1) and Apoa5 recombinant protein (2).